Pulmatrix - Stock Price History | PULM
Historical daily share price chart and data for Pulmatrix since 2021 adjusted for splits. The latest closing stock price for Pulmatrix as of October 22, 2021 is 0.70.
- The all-time high Pulmatrix stock closing price was 181.25 on March 21, 2014.
- The Pulmatrix 52-week high stock price is 3.04, which is 334.3% above the current share price.
- The Pulmatrix 52-week low stock price is 0.68, which is 2.9% below the current share price.
- The average Pulmatrix stock price for the last 52 weeks is 1.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pulmatrix Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2020 |
1.3754 |
1.6200 |
1.9700 |
0.9176 |
1.1900 |
38.37% |
| 2019 |
1.1006 |
2.7000 |
3.2830 |
0.6800 |
0.8600 |
-64.18% |
| 2018 |
6.7152 |
14.2000 |
19.9000 |
2.4010 |
2.4010 |
-82.97% |
| 2017 |
23.5015 |
5.9990 |
51.0000 |
5.5100 |
14.1000 |
138.98% |
| 2016 |
20.9869 |
38.3000 |
42.5000 |
5.6000 |
5.9000 |
-85.95% |
| 2015 |
75.4266 |
88.0000 |
126.5000 |
34.1000 |
42.0000 |
-52.00% |
| 2014 |
136.6268 |
181.2500 |
181.2500 |
84.0000 |
87.5000 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.039B |
$0.013B |
|
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
|
